reference/9961270

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9961270

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	695
issn	1556-0864
issueIdentifier	5
pageRange	688-695
publicationName	Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
startingPage	688
bibliographicCitation	Yang CH, Simms L, Park K, Lee JS, Scagliotti G, Orlando M. Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trial. J Thorac Oncol. 2010 May;5(5):688–95. doi: 10.1097/jto.0b013e3181d1273d. PMID: 20150825.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6646-958X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d6127095553bb11354ff713539cd8b6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d3e84b3464de1a72128ae71383cb3b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74dd295d62d35ea7121415ed10a52856 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdde301f6d4dd9313e261b488686fdf7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5586-5138 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6c72f41e0018a312d09303e4a1a5261 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bda6fd05dc5cc250677f27121e132402
date	201005
identifier	https://doi.org/10.1097/jto.0b013e3181d1273d https://pubmed.ncbi.nlm.nih.gov/20150825
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33311 https://portal.issn.org/resource/ISSN/1556-0864
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and Safety of Cisplatin/Pemetrexed Versus Cisplatin/Gemcitabine as First-Line Treatment in East Asian Patients with Advanced Non-small Cell Lung Cancer: Results of an Exploratory Subgroup Analysis of a Phase III Trial
discusses	http://id.nlm.nih.gov/mesh/M0227083 http://id.nlm.nih.gov/mesh/M0004505 http://id.nlm.nih.gov/mesh/M0009679 http://id.nlm.nih.gov/mesh/M0009376 http://id.nlm.nih.gov/mesh/M000754277 http://id.nlm.nih.gov/mesh/M0005997
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002294Q000188 http://id.nlm.nih.gov/mesh/D002289Q000188 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D018287Q000188 http://id.nlm.nih.gov/mesh/D008175Q000188 http://id.nlm.nih.gov/mesh/D000230Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D003841Q000031 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D003841Q000008 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D007390 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D018287Q000473 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D012449 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D002289Q000473 http://id.nlm.nih.gov/mesh/D006147Q000008 http://id.nlm.nih.gov/mesh/D002945Q000008 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D006147Q000031 http://id.nlm.nih.gov/mesh/D000230Q000473 http://id.nlm.nih.gov/mesh/D002294Q000473 http://id.nlm.nih.gov/mesh/D000093542 http://id.nlm.nih.gov/mesh/D005971Q000008 http://id.nlm.nih.gov/mesh/D000068437
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129439837 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764

Total number of triples: 72.